Oesophago gastric cancer the disease and the challenges Muntzer - - PowerPoint PPT Presentation

oesophago gastric cancer the disease and the challenges
SMART_READER_LITE
LIVE PREVIEW

Oesophago gastric cancer the disease and the challenges Muntzer - - PowerPoint PPT Presentation

Oesophago gastric cancer the disease and the challenges Muntzer Mughal Oesophago gastric cancer How common is it? What causes it? What are the symptoms? How is it treated? Recent advances in: Detection


slide-1
SLIDE 1

Oesophago‐gastric cancer the disease and the challenges

Muntzer Mughal

slide-2
SLIDE 2
slide-3
SLIDE 3

Oesophago‐gastric cancer

How common is it?

What causes it?

What are the symptoms?

How is it treated?

Recent advances in:

  • Detection
  • Treatment

The future

slide-4
SLIDE 4
slide-5
SLIDE 5
slide-6
SLIDE 6
slide-7
SLIDE 7
slide-8
SLIDE 8
slide-9
SLIDE 9

10 20 30 40 50 Western Africa Northern Africa Micronesia Melanesia South Central Asia Eastern Africa Northern America Southern Africa South-Eastern Asia Australia/New Western Asia Northern Europe Western Europe Middle Africa Caribbean Central America Southern Europe World South America Polynesia Eastern Europe Eastern Asia Rate per 100,000 population

Males Females

slide-10
SLIDE 10

5 10 15 20 25 30

Western Africa Middle Africa Northern Africa Central America Micro/Polynesia Western Asia South-Eastern Asia Southern Europe Australia/New Zealand Northern America Eastern Europe Melanesia Caribbean South America Western Europe Northern Europe South Central Asia Japan Eastern Africa Southern Africa China

Rate per 100,000 population Males Females

slide-11
SLIDE 11
slide-12
SLIDE 12

Stomach

7th commonest cancer

8200 new cases a year

6000 deaths a year Oesophagus

9th commonest cancer

7640 new cases a year

7400 deaths a year

slide-13
SLIDE 13

Scotland Northern North West Trent Anglia Wales N Thames S Thames N Ireland 2 4 6 8 10 12 14 16 18 20 per 1 0 0 ,0 0 0 population Oesophagus Stomach

slide-14
SLIDE 14

9th commonest cancer in the U.K

Commonly diagnosed at a late stage

  • UK

20% presenting as emergency

  • Japan

50% diagnosed early

5-year survival

  • Japan

41%

  • Europe

10%

  • UK

9%

slide-15
SLIDE 15
slide-16
SLIDE 16

Lifestyle

  • Alcohol
  • Smoking

Diet

  • Salty/pickled food

Obesity

Barrett’s oesophagus

slide-17
SLIDE 17

Diet

  • salty/pickled food

Lifestyle

  • Alcohol
  • Smoking

Infection

  • Helicobacter pylori
slide-18
SLIDE 18
slide-19
SLIDE 19

2 4 6 8 10 12 14 16 1975 1978 1981 1984 1987 1990 1993 1996 1999 2002 Year of diagnosis Rate per 100,000 population males females persons

slide-20
SLIDE 20

5 10 15 20 25 1993 1994 1995 1996 1997 1998 1999 2000 2001 2002 2003 2004 Year of diagnosis Rate per 100,000 population

males females persons

slide-21
SLIDE 21
slide-22
SLIDE 22

O‐G cancer symptoms

Indigestion that won’t go away

Difficulty with swallowing

Weight loss

Jaundice 

But even the earliest SYMPTOMS

  • ften associated with advanced

cancer

slide-23
SLIDE 23
slide-24
SLIDE 24
slide-25
SLIDE 25
slide-26
SLIDE 26
slide-27
SLIDE 27

6,137,325 examinations between 1968 – 1998

6394 cancers detected (0.104%)

Disease stage:

  • I

72.5%

  • II

10.3%

  • III

11.2%

  • IV

6%

slide-28
SLIDE 28
slide-29
SLIDE 29

Primary prevention

  • Public awareness –
  • besity, alcohol & smoking

Early diagnosis

  • Public awareness
  • Easier access to endoscopy

Surveillance & screening of high risk groups

  • Barrett’s

Better treatment

slide-30
SLIDE 30

GP

Disease free No or subtle symptoms Dysphagia, heartburn

slide-31
SLIDE 31
slide-32
SLIDE 32

Acceptability and accuracy of a non-endoscopic screening test for Barrett's oesophagus in primary care: cohort study.

Kadri SR et al

  • BMJ. 2010 Sep 10;341:c4372. doi: 10.1136/bmj.c4372
slide-33
SLIDE 33
slide-34
SLIDE 34

Extent of the disease

Scans

Inspection of abdominal cavity General level of fitness Tailoring to the individual

Palliative if advanced

Curative if localised

  • Surgery ±

chemotherapy/radiotherapy

slide-35
SLIDE 35
slide-36
SLIDE 36
slide-37
SLIDE 37

Stomach

Usually removal of whole stomach with lymph glands Oesophagus

Removal of major part of oesophagus & part

  • f stomach
slide-38
SLIDE 38

Most patients in 60s and 70s

Some have other medical problems

Operations are long & complex

Oesophagectomy involves opening the abdomen and the chest

Therefore, potentially high morbidity and mortality

slide-39
SLIDE 39

Gastrectomy

6 weeks off work, 6‐9 months to get back to ‘normal’

Smaller meals, difficulty regaining weight

Oesophagectomy

12 weeks off work, 12 months to get back to normal

Smaller meals, difficulty regaining weight

slide-40
SLIDE 40

1987 - 1991 1997 - 2000

Mortality after surgery 10% 5% 1-year survival 47% 62% 5-year survival 20% 31%

slide-41
SLIDE 41
slide-42
SLIDE 42

Better ‘mapping’ (staging) of the disease

Better tailoring of treatment

  • Multidisciplinary Team approach

Better surgery & after‐care

Endoscopic treatment of early disease

Key‐hole surgery!

Specialisation & centralisation

slide-43
SLIDE 43
slide-44
SLIDE 44

World‐class UGI gastroenterology service

  • Endoscopic treatment of early tumours
  • Interventional techniques – laser, stenting
  • Research

Excellent oncology services

Strong surgical service

  • 387 cases discussed and 82 resections since Feb

2011 with 1 death

  • Expertise for complex and re‐operative surgery

O‐G Cancer MDT at UCLH

slide-45
SLIDE 45

Covering population of 3.5 M

Appointment of O‐G Pathway Board Directors

  • David Khoo

(Queens Hospital in Romford)

  • Muntzer

Mughal

Programme to improve outcomes:

  • Earlier diagnosis
  • Smoother pathway through staging to treatment
  • Fewer centres for surgery
  • More enrolment of patients into trials
slide-46
SLIDE 46

Regional surgical centre

1.5 million population base

>600 cancers a year

>100 operations a year

6 experienced surgeons

slide-47
SLIDE 47

10 miles

slide-48
SLIDE 48

Preventative strategies

Public awareness

New tests for earlier detection

Better tests to show signs of spread

Safer and more effective chemotherapy

Safer and more effective surgery

Smaller proportion of patients will have surgery, but outcomes will be better